Role of T1 and T2 cytokines in the response to Mycobacterium tuberculosis

Annals of the New York Academy of Sciences

Volumn 795, Issue , 1996, Pages 137-146

  Flynn, Joanne L ^a   Bloom, Barry R ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; NITRIC OXIDE; RECOMBINANT INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; B LYMPHOCYTE; CELL CULTURE; CELLULAR IMMUNITY; COLONY FORMING UNIT; CONFERENCE PAPER; CONTROLLED STUDY; CYTOLYSIS; DISEASE PREDISPOSITION; FEMALE; HOST RESISTANCE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; SURVIVAL; T LYMPHOCYTE; TUBERCULOSIS;

EID: 0030467989     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1996.tb52662.x     Document Type: Conference Paper

References (36)

1. DOLIN, P. J., M. C. RAVIGLIONE & A. KOCHI. 1994. Global tuberculosis incidence and mortality during 1990-2000. Bull. W.H.O. 72: 213-220.
2. FLYNN, J. L., M. M. GOLDSTEIN, K. J. TRIEBOLD, B. KOLLER & B. R. BLOOM. 1992. Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc. Natl. Acad. Sci. USA 89: 12013-12017.
3. + T cell clones from Mycobacterium tuberculosis-immune mice. Infect. Immun. 54: 291-296.
4. LEVETON, C., S. BARNASS, B. CHAMPION, S. LUCAS, B. DE SOUZA, M. NICOL, D. BANERJEE & G. ROOK. 1989. T-cell mediated protection of mice against virulent Mycobacterium tuberculosis. Infect. Immun. 57.2: 390-395.
5. ORME, I. & F. COLLINS. 1984. Adoptive protection of the Mycobacteria tuberculosis-infected lung. Cell. Immun. 84: 113-120.
6. ORME, I. & F. COLLINS. 1983. Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. J. Exp. Med. 158: 74-83.
7. FLORY, C., R. HUBBARD & F. COLLINS 1992. Effects of in vivo T lymphocyte subset depletion on mycobacterial infections in mice. J. Leuk. Biol. 51: 225-229.
8. DENIS, M. 1991. Interferon-γ-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell. Immunol. 132: 150-157.
9. CHAN, J., Y. XING, R. MAGLIOZZO & B. R. BLOOM. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175: 1111-1122.
10. FLESCH, I. & S. KAUFMANN. 1991. Mechanisms involved in mycobacterial growth inhibition by gamma-interferon activated bone marrow macrophages: Role of reactive nitrogen intermediates. Infect. Immun. 59: 3213-3218.
11. CHAN, J., K. TANAKA, D. CARROLL, J. L. FLYNN & B. R. BLOOM. 1995. Effect of nitric oxide synthas inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 63: 736-740.
12. MUNOZ-FERNANDEZ, M. A., M. A. FERNANDEZ & M. FRESNO. 1992. Activation of human macrophages for the killing of intracellular Trypanosoma cruzi by TNF-α and IFN-γ through a nitric oxide-dependent mechanism. Immunol. Lett. 33: 35-40.
13. KOBZIK, L., D. S. BREDT, C. J. LOWENSTEIN, J. DRAZEN, B. GASTON, D. SUGARBAKER & J. S. STAMLER. 1993. Nitric oxide synthase in human and rat lung: Immunocytochemical and histochemical localization. Am. J. Respir. Cell. Mol. Biol. 9: 371-377.
14. DENIS, M. 1994. Human monocytes/macrophages: NO or no NO? J. Leuk. Biol. 55: 682-684.
15. DE MARIA, R., M. G. CIFONE, R. TROTTA, M. R. Rippo, C. FESTUCCIA, A. SANTONI & R. TESTI. 1994. Triggering of human monocyte activation through CD69, a member of the natural killer cell gene complex family of signal transducing receptors. J. Exp. Med. 180: 1999-2004.
16. BUKRINSKY, M. I., H. S. L. M. NOTTET, H. SCHMIDTMAYEROVA, L. DUBROVSKY, C. R. FLANAGAN, M. E. MULLINS, S. A. LIPTON & H. E. GENDELMAN. 1995. Regulation of nitric oxide synthase activity in human immunodeficiency virus Type 1 (HIV-1) infected monocytes: Implications for HIV-associated neurological disease. J. Exp. Med. 181: 735-745.
17. DALTON, D. K., S. PITTS-MEEK, S. KESHAV, I. S. FIGARI, A. BRADLEY & T. A. STEWART. 1993. Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science 259: 1739-1742.
18. FLYNN, J. L., J. CHAN, K. J. TRIEBOLD, D. K. DALTON, T. A. STEWARD & B. R. BLOOM. 1993. An essential role for interferon-γ in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178: 2249-2254.
19. COOPER, A. M., D. K. DALTON, T. A. STEWART, J. P. GRIFFEN, D. G. RUSSELL & I. M. ORME. 1993. Disseminated tuberculosis in IFN-γ gene-disrupted mice. J. Exp. Med. 178: 2243-2248.
20. FLYNN, J. L., M. M. GOLDSTEIN, J. CHAN, K. J. TRIEBOLD, K. PFEFFER, C. J. LOWENSTEIN, R. SCHREIBER, T. W. MAK & B. R. BLOOM. 1995. Tumor necrosis factor-α is required in the protective immune response against M. tuberculosis in mice. Immunity 2: 561-572.
21. SHEEHAN, K. C. F., N. H. RUDDLE & R. D. SCHREIBER. 1989. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. J. Immunol. 142: 3884-3893.
22. PFEFFER, K., T. MATSUYAMA, T. M. KUNDIG, A. WAKEHAM, K. KISHIHARA, A. AHAHINIAN, K. WIEGMANN, P. S. OHASHI, M. KRONKE & T. W. MAK. 1993. Mice deficient for the 55-kDa tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73: 457-467.
23. SYPEK, J. P., C. L. CHUNG, S. E. H. MAYOR, J. M. SUBRAMANYAM, S. J. GOLDMAN, D. S. SIEBURTH, S. F. WOLF & R. G. SCHAUB. 1993. Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helper Type 1 immune response. J. Exp. Med. 177: 1797-1802.
24. HEINZEL, F. P., D. S. SCHOENHAUT, R. M. RERKO, L. E. ROSSER & M. K. GATELY. 1993. Recombinant interleukin 12 cures mice infected with Leishmania major. J. Exp. Med. 177: 1505-1509.
25. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260: 547-549.
26. FINKELMAN, F. D., K. B. MADDEN, A. W. CHEEVER, I. M. KATONA, S. C. MORRIS, M. K. GATELY, B. R. HUBBARD, W. C. GAUSE J. F. URBAN. 1994. Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nemotode parasites. J. Exp. Med. 179: 1563-1572.
27. WYNN, T. A., I. ELTOUM, I. P. OSWALD, A. W. CHEEVER & A. SHER. 1994. Endogenous interleukin 12 regulates granulom formation induced by eggs of Schistosoma mansoni and exogenous IL-12 both inhibits and prophylatically immunizes against egg pathology. J. Exp. Med. 179: 1551-1561.
28. GAZZINELLI, R. T., S. HIENY, T. A. WYNN, S. WOLF & A. SHER. 1993. Interleukin 12 is required for the T-lymphocyte-independent induction of interferon-γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc. Natl. Acad. Sci. USA 90: 6115-6119.
29. TRIPP, C. S., M. K. GATELY, J. HAKIMI, P. LING & E. R. UNANUE. 1994. Neutralization of IL-12 decreases resistance to Listeria in SCID and C.B-17 mice-reversal by IFN-γamma. J. Immunol. 152: 1883-1887.
30. CHOMCZYNSKI, P. & N. SACCHI. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159.
31. FLYNN, J. L., M. M. GOLDSTEIN, K. J. TRIEBOLD, J. SYPEK, S. WOLF & B. R. BLOOM. 1995. IL-12 increases resistance of BALB/c mice to Mycobacteriuin tuberculosis infection. J. Immunol. 155: 2515-2524.
32. REINER, S. L., S. ZHENG, D. B. CORRY & R. M. LOCKSLEY. 1993. Constructing polycompetitor cDNAs for quantitative PCR. J. Immunol. Methods 165: 37-46.
33. AFONSO, L. C. C., T. SCHARTON, L. Q. VIEIRA, M. WYSOCKA, G. TRINCHIERI & P. SCOTT. 1994. The adjuvant effect of IL-12 in a vaccine against Leishmania major. Science 263: 235-237.
34. COOPER, A. M., A. D. ROBERTS, E. R. RHOADES, J. E. CALLAHAN, D. M. GETZY & I. M. ORME. 1995. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection. Immunology 84: 423-432.
35. LOCKSLEY, R. M. 1993. Interleukin-12 in host defense against microbial pathogens. Proc. Natl. Acad. Sci. USA 90: 5879-5880.
36. + αβ-TCR transgenic T cells is macrophage dependent. Int. Immunol. 5: 371-382.